RMY Stock Chart & Stats
€26.00
€0.20(0.78%)
At close: 4:00 PM EDT
€26.00
€0.20(0.78%)
Day’s Range― - ―
52-Week Range€17.10 - €26.80
Previous CloseN/A
Volume0.00
Average Volume (3M)0.00
Market Cap
€6.17B
Enterprise Value€20.25K
Total Cash (Recent Filing)€469.00M
Total Debt (Recent Filing)€17.53B
Price to Earnings (P/E)37.6
Beta0.65
Next Earnings
Aug 27, 2026EPS Estimate
0.4Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)1.18
Shares Outstanding230,829,800
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG Ratio-12.49
Price to Book (P/B)5.91
Price to Sales (P/S)1.67
P/FCF Ratio42.18
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€26.22Price Target Upside0.86% Upside
Rating ConsensusHold
Number of Analyst Covering9
EPS Forecast (FY)0.98
Revenue Forecast (FY)€11.79B
Bulls Say, Bears Say
Bulls Say
Australia Core Business StrengthSustained Australia growth underpins durable cash generation and margin resilience. Higher admissions, rising case acuity and improving theatre utilisation indicate capacity leverage and repeatable demand from private and public payors, supporting recurring facility revenue and investment returns over the medium term.
Improving Cash Flow And RefinancingMaterial OCF improvement and active refinancing reduce liquidity and interest-rate risk, improving debt servicing capacity and funding flexibility. Stronger cash conversion supports capex funding, dividends and strategic moves while hedging and extended tenor lower refinancing pressure over the next 2-6 months.
Capital Discipline And De‑riskingLower capex guidance and a planned Ramsay Sante demerger signal disciplined capital allocation and portfolio simplification. Redirecting development to high-return projects, pursuing a de‑risking distribution and targeted M&A (EPS accretive hospital) enhances strategic focus and should improve return on invested capital over time.
Bears Say
Elevated LeverageHigh group and Sante leverage constrain financial flexibility and amplify interest‑rate and refinancing risk. Even with hedges, material debt levels limit ability to absorb shocks, restrict opportunistic investment, and create dependency on steady cash generation and deleveraging actions to protect credit metrics over the medium term.
Sharp Profitability DeteriorationA collapse in net margin and ROE signals weaker profit conversion and lower capital efficiency. Persistently compressed margins limit internal funding for growth and dividends, increase sensitivity to cost inflation or payor cuts, and require sustained operational improvements to restore long‑term shareholder returns.
Payor And Regional Funding RiskReliance on mixed payor systems exposes earnings to public funding cycles, tariff indexation gaps and wage inflation. UK funding uncertainty, French subsidy cuts and local demand shortfalls in specialist units create persistent volume and pricing headwinds that can depress utilisation and margins across regions.
Ramsay Health Care News
RMY FAQ
What was Ramsay Health Care’s price range in the past 12 months?
Ramsay Health Care lowest stock price was €17.10 and its highest was €26.80 in the past 12 months.
What is Ramsay Health Care’s market cap?
Ramsay Health Care’s market cap is €6.17B.
When is Ramsay Health Care’s upcoming earnings report date?
Ramsay Health Care’s upcoming earnings report date is Aug 27, 2026 which is in 24 days.
How were Ramsay Health Care’s earnings last quarter?
Ramsay Health Care released its earnings results on Feb 25, 2026. The company reported €0.433 earnings per share for the quarter, beating the consensus estimate of €0.364 by €0.069.
Is Ramsay Health Care overvalued?
According to Wall Street analysts Ramsay Health Care’s price is currently Undervalued.
Does Ramsay Health Care pay dividends?
Ramsay Health Care does not currently pay dividends.
What is Ramsay Health Care’s EPS estimate?
Ramsay Health Care’s EPS estimate is 0.4.
How many shares outstanding does Ramsay Health Care have?
Ramsay Health Care has 230,829,800 shares outstanding.
What happened to Ramsay Health Care’s price movement after its last earnings report?
Ramsay Health Care reported an EPS of €0.433 in its last earnings report, beating expectations of €0.364. Following the earnings report the stock price went up 10.528%.
Which hedge fund is a major shareholder of Ramsay Health Care?
Currently, no hedge funds are holding shares in DE:RMY
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Ramsay Health Care Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
€26.22 (0.86% Upside)
€26.22 (0.86% Upside)
Blogger Sentiment
Bullish
DE:RMY Sentiment 75%
Sector Average ―
Sector Average ―
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-9.08%
12-Months-Change
Fundamentals
Return on Equity
2.17%
Trailing 12-Months
Asset Growth
13.13%
Trailing 12-Months
Company Description
Ramsay Health Care
Ramsay Health Care Limited is a prominent healthcare provider that manages and possesses hospitals. The company delivers medical services to both publicly funded and privately insured individuals. It maintains a substantial international presence, operating roughly 532 facilities across the Asia Pacific region, the United Kingdom, France, and the Nordic nations. Founded in 1964, its corporate headquarters are situated in Sydney, Australia.
RMY Stock 12 Month Forecast
Average Price Target
€26.22
▲(0.86% Upside)
Technical Analysis
Healius Limited
―
Regis Healthcare Ltd.
―
Sonic Healthcare Limited
―
Integral Diagnostics Ltd.
―
Australian Clinical Labs Ltd
―








